E-ISSN 2602-3164
EJMI. 2021; 5(2): 246-250 | DOI: 10.14744/ejmi.2021.40162

The Assessment of Volume Status with Body Composition Monitor in Cancer Patients

Saime Paydas1, Hande Ozonur2, Semra Paydas3, Bulent Kaya1, Ceren Efe4
1Division of Nephrology, Department of Internal Medicine, Cukurova University Faculty of Medicine, Adana, Turkey, 2Department of Internal Medicine, Cukurova University Faculty of Medicine, Adana, Turkey, 3Department of Oncology, Cukurova University Faculty of Medicine, Adana, Turkey, 4Department of Biostatistics, Cukurova University Faculty of Medicine, Adana, Turkey

Objectives: Intravenous (IV) fluid therapy is often needed in patients with the malignant disease during IV chemotherapy. The aim of our study is to evaluate the volume status of cancer patients treated with IV chemotherapy and standard fluid therapy by using body composition monitor (BCM) measurements. Methods: Thirty chemotherapy cycles of the 30 cancer patients were evaluated. Patients had solid tumors (10.7%) and lymphoproliferative disease (89.3%). Biochemical and hematological parameters and fluid status by using BCM were measured on the 1st and fifth days of chemotherapy cycles. Results: Hypovolemia or hypervolemia were found both at baseline and 5. day during IV fluid and chemotherapy in cancer patients (1.057±1.68 and 0.78±1.63 p>0.05 respectively). Also according to baseline, serum levels of Na, K, Ca, and body weight were decreased (p<0.04 for all), and CRP increased (p<0.02) on the 5th day. Conclusion: BCM measurements for fluid status revealed hypo/hypervolemia both at baseline and the 5. Day during chemotherapy. Interestingly at 5.day serum CRP level increased and serum levels of Na, K, Ca decreased. So that technical assessment of volume status during IV chemotherapy and fluid therapy may reduce the risk of fluid and electrolyte disorders and inflammation. Keywords: Body composition monitoring, intravenous fluid therapy, malignancy patients


Cite This Article

Paydas S, Ozonur H, Paydas S, Kaya B, Efe C. The Assessment of Volume Status with Body Composition Monitor in Cancer Patients. EJMI. 2021; 5(2): 246-250

Corresponding Author: Saime Paydas

Full Text PDF PDF Download
EJMI & EJMI